Anaemia in the critically ill patient: monitoring of erythropoietin therapy. - Suppr | 超能文献

Anaemia in the critically ill patient: monitoring of erythropoietin therapy.

作者信息

Thomas Christian, Wiesner Christoph, Melchior Sebastian W, Thüroff Joachim W

机构信息

Department of Urology and Paediatric Urology, Johannes Gutenberg University, School of Medicine, Mainz, Germany.

出版信息

BJU Int. 2006 Jun;97(6):1161-4. doi: 10.1111/j.1464-410X.2006.06172.x.

DOI:10.1111/j.1464-410X.2006.06172.x

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Anaemia in the critically ill patient: monitoring of erythropoietin therapy.

BJU Int. 2006 Jun;97(6):1161-4. doi: 10.1111/j.1464-410X.2006.06172.x.

2

More than a decade of experience and still no consensus: controversies in iron therapy.十多年的经验积累，却仍未达成共识：铁剂治疗中的争议

Clin J Am Soc Nephrol. 2006 Sep;1 Suppl 1:S1-3. doi: 10.2215/CJN.02030606.

3

Response to the randomized trial of recombinant human erythropoietin in critically ill patients.重组人促红细胞生成素用于重症患者的随机试验的结果

Crit Care Med. 2007 Jun;35(6):1632. doi: 10.1097/01.CCM.0000266837.49803.D0.

4

Hypochromic erythrocytes (%): a reliable marker for recognizing iron-restricted erythropoiesis and predicting response to erythropoietin in anemic patients with myeloma and lymphoma.低色素红细胞（%）：识别铁限制红细胞生成及预测骨髓瘤和淋巴瘤贫血患者对促红细胞生成素反应的可靠标志物。

Ann Hematol. 2007 May;86(5):369-76. doi: 10.1007/s00277-007-0258-x. Epub 2007 Feb 14.

5

Diagnosis and management of iron-related anemias in critical illness.危重症中铁相关贫血的诊断与管理

Crit Care Med. 2006 Jul;34(7):1898-905. doi: 10.1097/01.CCM.0000220495.10510.C1.

6

Supporting epoetin alfa stimulated erythropoiesis: identifying appropriate iron levels: case study of the anemic patient.支持促红细胞生成素α刺激的红细胞生成：确定合适的铁水平：贫血患者的案例研究

Nephrol Nurs J. 2000 Dec;27(6):612-5.

7

Can erythropoietin eradicate red cell transfusions in the critically ill?促红细胞生成素能消除危重症患者的红细胞输注需求吗？

Crit Care Med. 2006 Sep;34(9):2490-1. doi: 10.1097/01.CCM.0000235671.59923.CF.

8

Impact of inflammation on nutrition, iron status, and erythropoietin responsiveness in ESRD patients.炎症对终末期肾病患者营养状况、铁状态及促红细胞生成素反应性的影响。

Nephrol Nurs J. 2000 Dec;27(6):616-22.

9

Efficacy of recombinant human erythropoietin in critically ill patients admitted to a long-term acute care facility: a randomized, double-blind, placebo-controlled trial.重组人促红细胞生成素对入住长期急性护理机构的重症患者的疗效：一项随机、双盲、安慰剂对照试验。

Crit Care Med. 2006 Sep;34(9):2310-6. doi: 10.1097/01.CCM.0000233873.17954.42.

10

Current and upcoming erythropoiesis-stimulating agents, iron products, and other novel anemia medications.当前及即将出现的促红细胞生成剂、铁剂产品及其他新型贫血治疗药物。

Adv Chronic Kidney Dis. 2009 Mar;16(2):117-30. doi: 10.1053/j.ackd.2008.12.010.

引用本文的文献

1

Harms of off-label erythropoiesis-stimulating agents for critically ill people.危重症患者使用非标签促红细胞生成素刺激剂的危害。

Cochrane Database Syst Rev. 2017 Aug 25;8(8):CD010969. doi: 10.1002/14651858.CD010969.pub2.